abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Revenue
$79.82M
TTM · Period ending: · USD
HQL Revenue
Latest reported$79.82Mperiod ending
Latest reported$79.82Mperiod ending
HQL Revenue ($420.00K → $79.82M)
Annual revenue
High-resolution chart · PNG
HQL revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue (USD) |
|---|---|
| 86,385,919 | |
| 86,685,230 | |
| 39,385,072 | |
| 31,862,397 | |
| 45,024,146 | |
| 39,071,648 | |
| 2,440,586 | |
| 1,985,823 | |
| 69,811,313 | |
| 6,291,311 | |
| 1,322,603 | |
| 876,788 | |
| 516,758 | |
| 2,144,505 | |
| 570,000 | |
| 1,820,000 | |
| 460,000 | |
| 1,670,000 | |
| 2,880,000 | |
| 2,300,000 | |
| 890,000 | |
| 320,000 | |
| 610,000 | |
| 940,000 | |
| 1,770,000 | |
| 140,000 | |
| 320,000 | |
| 420,000 |